Maxim Pharmaceuticals, Inc. v. Crosspoint Venture Partners 1997, L. P.

546 U.S. 819, 126 S. Ct. 348, 163 L. Ed. 2d 58, 74 U.S.L.W. 3202, 2005 U.S. LEXIS 5609
Supreme Court of the United States·Decided October 3, 2005·No. No. 04-1590·Published

Opinion

Ct. App. Cal., 4th App. Dist., Div. 1. Certiorari denied.

Free access — add to your briefcase to read the full text and ask questions with AI

Maxim Pharmaceuticals, Inc. v. Crosspoint Venture Partners 1997, L. P., 546 U.S. 819, 126 S. Ct. 348, 163 L. Ed. 2d 58, 74 U.S.L.W. 3202, 2005 U.S. LEXIS 5609 (2005).

546 U.S. 819 (Maxim Pharmaceuticals, Inc. v. Crosspoint Venture Partners 1997, L. P.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.